Metabolic effects of L-carnitine on type 2 diabetes mellitus: Systematic review and meta-analysis

Experimental and Clinical Endocrinology and Diabetes

Volumn 121, Issue 4, 2013, Pages 234-238

  Vidal Casariego, A ^a   Burgos Pelaez R ^b   Martinez Faedo C ^c   Calvo Gracia, F ^d   Valero Zanuy, M A ^e   Luengo Perez L M ^f   Cuerda Compes C ^g  

^a Complejo Asistencial Universitario de León   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f HOSPITAL INFANTA CRISTINA   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

apolipoprotein A1; apolipoprotein B100; lipoprotein(a); low density lipoprotein; oxidative stress; total cholesterol; tryglicerides

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; CARNITINE; GLUCOSE; HEMOGLOBIN A1C; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

AMINO ACID BLOOD LEVEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COCHRANE LIBRARY; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; MEDLINE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

APOLIPOPROTEIN A-I; APOLIPOPROTEIN B-100; BLOOD GLUCOSE; CARNITINE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FASTING; HUMANS; INSULIN; LIPIDS; LIPOPROTEINS, LDL; MEDLINE; POSTPRANDIAL PERIOD; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84876494766     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0033-1333688     Document Type: Article

References (17)

1. Mingrone G. Carnitine in type 2 diabetes. Ann N Y Acad Sci: 2004; 1033 99 107 (Pubitemid 39656742)
2. Mynatt R. L. Carnitine and type 2 diabetes. Diabetes Metab Res Rev: 2009; 25 S45 S49
3. Ferrannini E., Buzzigoli G., Bevilacqua S. et al. Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol: 1988; 255 E946 E952
4. Stephens F. B., Constantin-Teodosiu D., Greenhaff P. L. New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol: 2007; 581 431 444 (Pubitemid 46831747)
5. Stephens F. B., Constantin-Teodosiu D., Laithwaite D. et al. An acute increase in skeletal muscle. J Clin Endocrinol Metab: 2006; 91 5013 5018
6. Mingrone G., Greco A. V., Capristo E. et al. L-carnitine improves glucose disposal in type 2 diabetic patients. J Am Coll Nutr: 1999; 18 77 82 (Pubitemid 29088689)
7. Capaldo B., Napoli R., Di Bonito P. et al. Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract: 1991; 14 191 195
8. Poorabbas A., Fallah F., Bagdadchi J. et al. Determination of free L-carnitine levels in type II diabetic women with and without complications. Eur J Clin Nutr: 2007; 61 892 895 (Pubitemid 47040313)
9. Ringseis R., Keller J., Eder K. Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine defi ciency. J Nutr: 2012; 51 1 18
10. Derosa G., Cicero A. F., Gaddi A. et al. The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin Ther: 2003; 25 1429 1439 (Pubitemid 36677286)
11. Rahbar A. R., Shakerhosseini R., Saadat N. et al. Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type 2 diabetes mellitus. Eur J Clin Nutr: 2005; 59 592 596 (Pubitemid 40528674)
12. Santo S. S., Sergio N., Luigi D. P. et al. Effect of LPC on functional parameters and oxidative profile in type 2 diabetes-associated PAD. Diabetes Res Clin Pract: 2006; 72 231 237 (Pubitemid 43729146)
13. Malaguarnera M., Vacante M., Avitabile T. et al. L-carnitine supplementation reduces oxidiced LDL cholesterol in patients with diabetes. Am J Clin Nutr: 2009; 89 71 76
14. Ringseis R., Keller J., Eder J. Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies. with carnitine supplementation and carnitine deficiency. Eur J Nutr: 2012; 51 1 18
15. Ceriello A., Quagliaro L., Piconi L. et al. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes: 2004; 53 701 710 (Pubitemid 38270640)
16. Cuerda C., Luengo L. M., Valero M. A. et al. Antioxidantes y diabetes mellitus: revisión de la evidencia. Nutr Hosp: 2011; 26 68 78
17. Valero M. A., Vidal A., Burgos R. et al. Meta-analysis on the role of lycopene in type 2 diabetes mellitus. Nutr Hosp: 2011; 26 1236 1241